Senescent Cells: Therapeutic Target, Biological Signal, or Red Herring? Longevity Series Brief Summary This article explores one of the most intriguing questions in modern geroscience: whether senescent cells are actionable therapeutic targets or merely biological bystanders associated with aging and chronic disease. The answer
Tag: Longevity medicine
Healthspan vs. Lifespan: Are We Measuring the Years That Matter?
Healthspan vs. Lifespan: Are We Measuring the Years That Matter? Longevity Series Brief Summary This article explores the growing distinction between lifespan and healthspan. Lifespan asks how long people live. Healthspan asks how much of that life is lived with preserved function, independence, cognition, mobility,
Immune Aging (Immunosenescence) The Next Major Target for Longevity Medicine
Immune Aging (Immunosenescence) The Next Major Target for Longevity Medicine Abstract The human immune system undergoes gradual decline with advancing age, a process termed immunosenescence. This deterioration represents one of the most promising targets for extending healthy lifespan. Research demonstrates that immune aging contributes to
Muscle Aging and Sarcopenia: Are Senolytics the Missing Piece?
Muscle Aging and Sarcopenia: Are Senolytics the Missing Piece? Abstract Age-related muscle loss, known as sarcopenia, affects millions of older adults worldwide. This condition leads to decreased strength, mobility, and independence while increasing fall risk and mortality. Traditional treatments focus on exercise and
The Cancer Risk Paradox of Anti-Aging Therapies
The Cancer Risk Paradox of Anti-Aging Therapies Abstract The relationship between anti-aging interventions and cancer risk presents a complex biological paradox that demands careful examination by healthcare practitioners. While many anti-aging therapies aim to promote cellular health and longevity, they may inadvertently create conditions that
Hidden Crisis: Why Sarcopenia Treatment Matters More Than You Think in 2025
Hidden Crisis: Why Sarcopenia Treatment Matters More Than You Think in 2025 Introduction Sarcopenia treatment represents a critical healthcare priority as the prevalence of this age-related muscle wasting condition reaches alarming levels. The economic burden of sarcopenia in the United States was approximately
